-
The CRYOcheck™ Factor VIII deficient plasma with VWF from Alpha Laboratories.
Laboratory products
Achieve Confidence in your APTT Testing Results
Feb 07 2022
Convenient kit improves assay performance
If you are running the one-stage activated partial thromboplastin time (APTT) method to help manage your haemophilia A patients, the new CRYOcheck™ Factor VIII deficient plasma with Von Willebrand Factor (VWF), from Precision Biologic, could improve your assay performance.
Available from Alpha Laboratories, it is currently the only commercially available manufactured Factor VIII deficient plasma that compares to using congenital Factor VIII deficient plasma. Since access to congenital FVIII deficient plasma is limited and has high donor variability and small pool sizes, this newly available product provides enhanced convenience and increased confidence in testing results.
The CRYOcheck™ Factor VIII deficient plasma with VWF is manufactured from platelet-poor plasma. It has been immunodepleted of FVIII and then purified VWF is reintroduced to normal levels. FVIII has been assayed at less than 1% normal antigen and activity levels, with VWF antigen and activity levels at >50%. The plasma is buffered and frozen, with the frozen format eliminating reconstitution errors and a 24-hour stability once thawed if refrigerated at 2°C-8°C in the original capped vial.
Precision Biologic provides a full range of factor deficient plasmas, plus the Chromogenic Factor VIII and Factor VIII Inhibitor diagnostic kits.
More information online
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



